Clinical trial
Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill Patients
NCT01426165 is registered in ClinicalTrials.gov with CAMC Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill Patients
- Lead sponsor
- CAMC Health System
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2011
- Completion date
- December 31, 2012
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary hypomagnesemia (disorder)